Oncolytics Biotech (ONCY) Other Working Capital Changes (2018 - 2025)

Oncolytics Biotech (ONCY) has 8 years of Other Working Capital Changes data on file, last reported at -$73390.1 in Q3 2025.

• On a quarterly basis, Other Working Capital Changes fell 25.14% year-over-year to -$73390.1 in Q3 2025; TTM through Sep 2025 was -$290372.1, a 12.11% decrease from a year earlier, with the FY2025 full-year figure at -$293000.0, down 15.81% from the prior year.
• Other Working Capital Changes for Q3 2025 stood at -$73390.1, roughly flat from -$73614.7 in the prior quarter.
• Over the last five years, Other Working Capital Changes for ONCY reached as high as -$47524.1 in Q2 2024 and fell as low as -$88232.7 in Q1 2021.
• Historically, Other Working Capital Changes has averaged -$71534.8 across 5 years, with a median of -$73607.6 in 2022.
• Across the five-year window, Other Working Capital Changes surged 36.16% in 2024 and sank 54.9% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at -$63862.0 in 2021, then fell by 17.67% to -$75143.7 in 2022, then retreated by 1.66% to -$76391.7 in 2023, then climbed by 6.29% to -$71584.9 in 2024, then declined by 2.52% to -$73390.1 in 2025.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$73390.1 in Q3 2025, -$73614.7 in Q2 2025, and -$71782.4 in Q1 2025.